@article{article, title  = {{Choice of androgen receptor pathway inhibitors (ARPi) by disease volume and timing of metastases in metastatic hormone sensitive prostate cancer (mHSPC).}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{https://doi.org/10.1200/jco.2025.43.5_suppl.184 }},

 year = {{2025}},

 month = {{2}},

 author = {{Naqvi SAA and Faisal KS and Khakwani KZR and Childs DS and Orme J and Andrews J and Ravi P and Hussain SA and Agarwal N and Singh P and Zakharia Y et al}},

 doi = {{10.1200/jco.2025.43.5_suppl.184}},

 volume = {{43}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{5_suppl}},

 pages = {{184-184}},

 note = {{Accessed on 2025/03/10}}}